GlassScriptPhysician profile
Mary Esancy
NPI 1649751975
$1,529.14
in general payments reported to CMS, 2019-2025
21 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.33 · 2023: $26.32 · 2024: $984 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475 · Education: $38.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,474.59 |
| Education | $38.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $333.05 | 2024-2025 | |
| Philips North America LLC | $164.03 | 2024-2025 | Extended Holter, (5044) Mcot, (5050) Extended Holter |
| Novo Nordisk INC | $144.65 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Boston Scientific Corporation | $105.38 | 2021-2025 | Varithena Administration Pack, Watchman Access System |
| Pfizer INC. | $91.29 | 2024-2025 | |
| Scpharmaceuticals INC. | $75.43 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $71.55 | 2024 | Camzyos |
| Amgen INC. | $68.29 | 2024-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $65.19 | 2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $57.23 | 2024-2025 | |
| Medicomp INC | $57.08 | 2024 | Telepatch Cardiac Monitor |
| Astrazeneca Pharmaceuticals LP | $52.64 | 2024-2025 | Lokelma |
| Medtronic, INC. | $48.64 | 2024 | Closurefast |
| Abbott Laboratories | $45.76 | 2024-2025 | Confirm Rx, Jot Dx |
| Lilly USA, LLC | $31.24 | 2025 | Zepbound |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $26.32 | 2023 | |
| Sanofi-Aventis U.S. LLC | $23.25 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $22.20 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $18.16 | 2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $15.87 | 2024 | Xarelto |
| Vivaquant INC, Dba Rhythm Express | $11.89 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Esancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.